Clear definition of new drugs urged

Domestic R&D based pharmaceutical firms have recently contended that more clear definition of new drugs and their license standards need to be re-established, as the current approval of Korean new drugs have been made via three different laws and regulation, such as Pharmaceutical Affairs Law, Natural New Drug Development Promotion Law and rule concerning the designation of new orphan drugs, an...